Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 194

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: A Gynecologic Oncology Group study

von Gruenigen, Vivian E., Tian, Chunqiao, Frasure, Heidi, Waggoner, Steven, Keys, Henry, Barakat, Richard R. · 2006 · Cancer

Abstract

BACKGROUND.: The objective was to examine whether rates of disease recurrence, treatment‐related adverse effects, and survival differed between obese or morbidly obese and nonobese patients. METHODS.: Data from patients who participated in a randomized trial of surgery with or without adjuvant radiation therapy were retrospectively reviewed. RESULTS.: Body mass index (BMI) data were available for 380 patients, of whom 24% were overweight (BMI, 25–29.9), 41% were obese (BMI, 30–39.9), and 12% were morbidly obese (BMI, ≥40). BMI did not significantly differ based on age, performance status, histology, tumor grade, myometrial invasion, or lymphovascular‐space involvement. BMI > 30 was more common in African Americans (73%) than non‐African Americans (50%). Patients with a BMI ≥ 40 compared with BMI < 30 (hazards ratio [HR], 0.42; 95% confidence interval [CI], 0.09–1.84; P = .246) did not have lower recurrence rates. Compared with BMI < 30, there was no significant difference in survival in patients with BMI 30–39.9 (HR, 1.48; 95% CI, 0.82–2.70; P = .196); however, there was evidence for decreased survival in patients with BMI ≥ 40 (HR, 2.77; 95% CI, 1.21–6.36; P = .016). Unadjusted and adjusted BMI hazards ratios for African Americans versus non‐African Americans in the current study differed, thus suggesting a confounding effect of BMI on race. Eight (67%) of 12 deaths among 45 morbidly obese patients were from noncancerous causes. For patients who received adjuvant radiation therapy, increased BMI was significantly associated with less gastrointestinal (R, −0.22; P = .003) and more cutaneous (R, 0.17; P = .019) toxicities. RESULTS.: In the current study, obesity was associated with higher mortality from causes other than endometrial cancer but not disease recurrence. Increased BMI was also associated with more cutaneous and less gastrointestinal toxicity in patients who received adjuvant radiation therapy. Future recommendations include lifestyle intervention trials to improve survival in obese endometrial cancer patients. Cancer 2006. © 2006 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.22351

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 194

Metadata

Authors
von Gruenigen, V. E., Tian, C., Frasure, H., Waggoner, S., Keys, H., & Barakat, R. R.
Venue
Cancer
Publisher
Wiley
Published
2006-12-08
Volume
107
Issue
12
Pages
2786-2791
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2006426441
Cited by
194
References
2
FWCI
5.77
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: A Gynecologic Oncology Group study. https://app.cochat.ai/papers/10.1002/cncr.22351
The paper
von Gruenigen, V. E., Tian, C., Frasure, H., Waggoner, S., Keys, H., & Barakat, R. R. (2006). Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma: A Gynecologic Oncology Group study. Cancer. https://doi.org/10.1002/cncr.22351

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.